VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1812831
Sex: F
Age:
State: NC

Vax Date: 05/10/2021
Onset Date: 05/18/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 2021; Test Name: X-ray; Result Unstructured Data: Test Result:unknown results; Comments: her daughter went to the dentist on Monday and they took x-rays

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: rash after second vaccine/same little rash got on her daughters back; Itching; little bumps or pimples on both of her daughters arms; little bumps or pimples on both of her daughters arms; her face, and her back, and it is really bad on her arms. It is just huge welts.; This is a spontaneous report from a contactable consumer or other non hcp (patient's mother). A 20-year-old female patient received bnt162b2 (PFIZER BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EW0172) via an unspecified route of administration on 10May2021 (age at vaccination 20 years) as dose 2, single for COVID-19 immunization. Additional vaccines administered on same date of the pfizer suspect was reported as none. The patient medical history was reported as no medications, may be a daily vitamin. Caller stated her daughter did not even use it like, she did not take anything. The patient's concomitant medications were not reported. The Patients medical history including any illness at time of vaccination was none. Family medical history included she and her daughter's husband both had side effects. Family medical history relevant to adverse events was reported as her dad had the vaccine, he was sick for several days with flu like symptoms but no rash. Caller stated herself, her mom, did not have any reactions at all except soreness at the injection site. Prior vaccinations within 4 weeks or any other vaccinations within four weeks prior to the first administration date of the suspect vaccines was none. AE(s) following prior vaccinations was none. The patient previously received bnt162b2 (PFIZER BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration on 14Apr2021 (Batch/Lot Number: EW0150) as dose 1, single for COVID-19 immunization and experienced tired (tired after the first one). The patient's past medications included flu shot and experienced soreness at the immunization site (she never had a reaction other than soreness at the immunization site). Caller added that her daughter was a very healthy person too, they took vitamins and probiotics. Caller was calling about the Pfizer Covid-19 Vaccine because her daughter had a reaction she would like to report. Caller has a family doctor she was going to take her, but they do not have one that she saw yet. Caller added that this was over 21 days on 10May2021. Caller was not sure about the location of the vaccines, but thought her daughter probably got it in the left arm because her daughter was right-handed. She probably would have said left. She experienced rash after second vaccine on 18May2021 it started 2 to 3 days ago like little bumps or pimples on both of her daughter's arms. Then, the same little rash got on her daughters back. That was like, she got the shot on 10May2021. By wednesday or thursday, she had a little rash. Then, today, her daughter works up and it looks awful like welts. It looks like welts like maybe she got into poison oak. It was on her face, and her back, and it was really bad on her arms. It was just huge welts on an unspecified date in 2021. Caller was heard telling her daughter she told Pfizer the pimple stuff started day 3. After discussion, the caller told her daughter it had to have been day 3 because she had the little pimple stuff at the beach. Caller daughter responded no, and that was just her skin and always there, and it had to have been around day 7. Caller stated that her daughter said the correction, and it was actually the raised bumps were always there. The actual rash started on day 7. Caller stated as soon as she hung up, she was going to get calamine lotion and oatmeal bath because it was really itching her daughter now. Caller added they were going to treat it like chicken pox. It was just a little bit, it did not really bother her daughter, but today when her daughter woke up and showed her it mortified her as a mom. It looked awful. She was going to give her Benadryl and do an oatmeal bath and calamine lotion. Caller added she would also ask the pharmacist what else they recommend. Caller added she and her husband were both over 60 and had the vaccine and had 0 reactions. Caller added that she hopes that people that get these rashes, it did not go into breathing issues like severe hives. The patient underwent lab tests and procedures which included x-ray: unknown results on an unspecified date in 2021 (her daughter went to the dentist on Monday, and they took x-rays and was a pre-planned dental cleaning). Adverse events did not result in Emergency Room or Physician Office. Relevant tests were none. The outcome of the events was unknown. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1812832
Sex: M
Age:
State: CA

Vax Date: 05/08/2021
Onset Date: 05/01/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210601; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Negative

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: cough; This is a spontaneous report from a contactable physician. A 16-years-old male patient received bnt162b2 (PFIZER COVID-19 VACCINE, Solution for injection, Batch/Lot number: EW0172), dose 1 via an intramuscular route of administration, administered in Arm Right on 08May2021 12:00 as DOSE 1, SINGLE for covid-19 immunisation (at the age of 16 years). Medical history included seasonal allergy from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient was not diagnosed with COVID prior to vaccination. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. No other medications the patient received within 2 weeks of vaccination. The patient experienced cough on May2021. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 01Jun2021 (If COVID tested post vaccination: Yes). Therapeutic measures were taken as result of cough included scheduled non-steroidal anti-inflammatory drugs (NSAIDs). The clinical outcome of the event was recovering. Follow-Up (26Aug2021): Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1812833
Sex: M
Age:
State: TX

Vax Date: 05/18/2021
Onset Date: 05/24/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Rash all down arm that the shot was given in. The rash has now gone into the other arm and below both arm pits.; Itching occurring on both legs; This is a spontaneous report from a contactable consumer or other non hcp (Patient). A 38-years-old male patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch number: not reported/Lot Number: EW0175), via an unspecified route of administration, administered in arm right on 18May2021 (Age at vaccination 38-years-old), as dose 1, single for covid-19 immunization. The patient medical history included seasonal allergies. Patient received steroid shot for seasonal allergies within 2 weeks of vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination patient was not diagnosed with Covid. Since the vaccination patient has not been tested for COVID-19. On 24May2021, the patient experienced rash all down arm that the shot was given in. The rash has now gone into the other arm and below both arm pits, itching occurring on both legs. Timeframe between vaccination and starting of symptoms was 6 days. Therapeutic measures were not taken as a result of the events. Clinical outcome of the events was unknown. Information on Lot/Batch number was available. Additional information has been requested.

Other Meds:

Current Illness:

ID: 1812834
Sex: F
Age:
State: TX

Vax Date: 03/01/2021
Onset Date:
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: some mild inflammation; This is a spontaneous report from a contactable consumer, the patient. A 53-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: EP6955), dose 1 via an unspecified route of administration, administered in arm left on Mar2021 as dose 1, single (at the age of 53-years-old) for covid-19 immunisation. The patient was non-pregnant at the time of vaccination. Medical history included mild osteo arthritis. Concomitant medications included estradiol and progesterone. The patient experienced some mild inflammation on an unspecified date. The patient received anti-inflammatory and flexorall as treatment for the event. The patient did not receive any other vaccines within 4 weeks prior to the covid vaccine. The patient had not diagnosed with covid-19 prior to vaccination and had not tested for covid-19 since the vaccination. The outcome of the event was not recovered. Follow-up attempts were completed. No further information was expected.

Other Meds: ESTRADIOL; PROGESTERONE

Current Illness:

ID: 1812835
Sex: F
Age:
State: TX

Vax Date: 04/15/2021
Onset Date: 04/26/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: After the second shot, major inflammation; Extreme shoulder, arm and neck pain; Extreme shoulder, arm and neck pain; Extreme shoulder, arm and neck pain; Sleeping has also been very difficult; This is a spontaneous report from a contactable consumer or other non hcp (patient) and Other HCP. A 53-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: ER8731) via an un-specified route of administration, administered in left arm on 15Apr2021 11:15 (at the age of 53-year-old) at dose 2, single for covid-19 immunisation. Medical history included mild osteo arthritis. Patient had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Concomitant medications included estradiol (ESTRADIOL); progesterone (PROGESTERONE), both taken for an unspecified indication, start and stop date were not reported, patient received them within 2 weeks of vaccination. Patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EP6955) via an unspecified route of administration, administered in left arm on an unspecified date in Mar2021 11:15 (at the age of 53-year-old) at dose 1, single for covid-19 immunisation and experienced mild inflammation. On 26Apr2021 the patient experienced after the second shot, major inflammation, extreme shoulder, arm and neck pain, sleeping has also been very difficult. Reported Event: After the first shot, some mild inflammation. After the second shot, major inflammation. Day 12 after 2nd dose, extreme shoulder, arm and neck pain. Saw Dr. on day 16. I have been in Physical Therapy since May 11th working on the pain. I have been unable to wear my wedding rings since the second dose. Sleeping has also been very difficult. Adverse events resulted in doctor or other healthcare professional office/clinic visit. Patient received treatment with anti-inflammatory, flexorall for the adverse events. Outcome of the events was not resolved. Follow-Up (30Jun2021): Follow-up attempts are completed. No further information is expected.

Other Meds: ESTRADIOL; PROGESTERONE

Current Illness:

ID: 1812836
Sex: F
Age:
State: NC

Vax Date: 06/02/2021
Onset Date: 06/03/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Within 12 hours of my second Pfizer COVID19 vaccination, my right breast had a 6cm area that was very red. 8 hors after that, the area had grown to approximately 10cm and was a darker, "angry" lookin; Within 12 hours of my second Pfizer COVID19 vaccination, my right breast had a 6cm area that was very red. 8 hors after that, the area had grown to approximately 10cm and was a darker, "angry" lookin; This is a spontaneous report from a contactable consumer (patient) reported for herself that. A 53-years-old female patient received BNT162B2 (BNT162B2 solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 02Jun2021 15:15 (Batch/Lot Number: EW0168) as DOSE 2, SINGLE for covid-19 immunization (Age at vaccination 53 years). Facility where the most recent COVID-19 vaccine was administered: Pharmacy or Drug Store. The patient past medical history included breast cancer from an unknown date and unknown if ongoing (occult primary, 1 lymph node of right axilla, ER-, PR+, HER2+), photon radiation therapy to breast from 12Oct2020 to an unknown date 25th day of radiation treatment.The patient previously received BNT162B2 (BNT162B2 solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 12May2021 15:30 (Batch/Lot Number: EW0167) as DOSE 1, SINGLE for covid-19 immunization.Concomitant medication(s) included bupropion hydrochloride (WELLBUTRIN XL) taken for an unspecified indication, start and stop date were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine within 4 weeks prior to covid-19 vaccination. On 03Jun2021 at 02:30 am the patient reported Within 12 hours of her second Pfizer COVID19 vaccination, her right breast had a 6cm area that was very red. 8 hours after that, the area had grown to approximately 10cm and was a darker, angry looking red, with almost purple veining. (This is the same breast that received radiation for cancer. My 25th day of radiation treatment was on October 12, 2020.) she contacted her radiology oncologist and am waiting to hear from her. No treatment was received. The event outcome was not recovered. Device Date: 03Jun2021 Follow up attempts needed. Further information is expected

Other Meds: WELLBUTRIN XL

Current Illness:

ID: 1812837
Sex: F
Age:
State: PA

Vax Date: 05/18/2021
Onset Date: 05/18/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210703; Test Name: Blood Pressure; Result Unstructured Data: Test Result:120/70 mmHg; Comments: Blood Pressure: 120/70 Blood Pressure Location: Lt brachial Blood Pressure Position: sitting; Test Date: 20210703; Test Name: Height; Result Unstructured Data: Test Result:5 ft 5 in; Comments: Height: 5 ft 5 in; Test Date: 20210703; Test Name: Body Mass Index BMI; Result Unstructured Data: Test Result:23.2; Comments: Body Mass Index BMI: 23.2; Test Date: 20210703; Test Name: Temperature; Result Unstructured Data: Test Result:96.9 Fahrenheit; Comments: Temperature: 96.9 F L Temperature Source: Temporal Artery Scan; Test Name: Temperature; Result Unstructured Data: Test Result:99.9 Fahrenheit; Test Date: 20210703; Test Name: Pulse Rate; Result Unstructured Data: Test Result:118; Comments: Pulse Rate: 118 H Pulse Source: Monitor; Test Name: Exam; Result Unstructured Data: Test Result:Normal; Test Date: 20210703; Test Name: 02 Sat b Pulse Oximeter; Test Result: 98 %; Comments: 02 Sat b Pulse Oximeter (%): 98 Oxygen Deliver Method: room air; Test Date: 20210703; Test Name: weight; Result Unstructured Data: Test Result:139 lb 6 oz; Comments: Weight: 139 lb 6 oz

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: stomach cramping and pain; nausea; dizzy spells; painful; lymph nodes became very swollen and painful again; lumps in breasts; breast tenderness; lymph nodes became very swollen and painful again; Temperature: 99.9; This is a spontaneous report from a contactable consumer, the patient. This is the second of two reports. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0182), via an intramuscular route of administration in the left arm/deltoid on 18May2021 at 10:59 (at the age of 31-year-old) as DOSE 2, SINGLE for COVID-19 immunisation. Medical history included possible autoimmune issue, heart block, heart pvcs, previous ovarian tumours removed, ongoing asthma, ongoing GERD, ongoing Allergies, ongoing Anxiety, ongoing Type 1 AV Block, Raynaud's phenomenon, Vitamin D deficiency, ongoing post-traumatic stress disorder, palpitation, Elevated blood pressure, Acne, removal of ovarian cyst, She had family history of hypertension and depression for father and mother, her father had diabetes mellitus, Former smoker (In 2014, she quit smoking, 0.25 packs per day), Disordered eating, hives and welts. The patient had known allergies to sulpha, penicillin, seasonal allergies, strawberries, arugala, dairy, meat products, spices, silver allergy. Concomitant medications included oral Montelukast sodium (SINGULAR) for allergies (strength 10 mg) , oral fexofenadine hydrochloride (ALLEGRA) for allergies, nasal fluticasone propionate (FLONASE) daily for allergies (strength 50 mcg ), vitamin d nos (MANUFACTURER UNKNOWN) and oral fish oil (MANUFACTURER UNKNOWN) as a supplement, albuterol sulphate (strength 90 mcg) as needed ; oral ascorbic acid taken for an unspecified indication, oral cholecalciferol taken for an unspecified indication daily, clindamycin; tretinoin taken for an unspecified indication topical, oral cyanocobalamin taken for an unspecified indication daily, oral diazepam taken for an unspecified indication daily, epinephrine taken for an unspecified indication as needed, oral fexofenadine taken for an unspecified indication, oral metoprolol tartrate taken for an unspecified indication daily, oral omeprazole taken for an unspecified indication daily, oral glucosamine taken for supplementation therapy, oral collagen taken for supplementation therapy ongoing, oral vitamin b nos taken for supplementation therapy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0164) via Intramuscular route of administration in the left arm on 27Apr2021 at 10:59 (at the age of 31-years-old) as a single dose for COVID-19 immunisation and experienced painful lymph nodes in both breasts for 5 weeks plus fever 99- 101 on and off for 3 weeks after the first shot. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18May2021 at 11:00, the patient experienced stomach cramping and pain, nausea and dizzy spells. The events resulted in doctor or other healthcare professional office/clinic visit. On an unspecified date in 2021, She stated pain returned immediately after the second shot with the lymph nodes became very swollen and painful again. On an unspecified date in 2021, the patient temperature was 99.9. She thinks she has knots/lumps in breasts. She stated her breasts are 1-2 cup sizes larger which cannot be assessed. It was possible that she had a minor vaccine reaction. Patient was advised stay at the vaccination site for 30 minutes to be observed following administration. Advised patient that the incidence of anaphylaxis was extremely low. She got advice to continue her allergy medication and consider taking Pepcid if she develops any side effects and she take her EpiPen with her to the vaccination site. If she needs to use the Epi Pen, she should go immediately to the ER to be observed. On 03Jul2021, patient's blood pressure was 120/70 at Left brachial in sitting position, height was 5 feet 5-inch, Body Mass Index (BMI) was23.2, Temperature was 96.9 F L at Temporal Artery Scan and pulse rate was 118 (High), oxygen Sat b was 98 percent with Pulse Oximeter. Oxygen Deliver Method was room air and patient's weight were 139 lb 6 oz. On an unspecified date, lab test was performed and was normal. Positive appearance normal, both eyes and all related structures, no rashes or lesions noted, elasticity normal and turgor normal, patient alert, patient awake, patient oriented x3, gait normal, moves all extremities, no meningeal signs and no focal motor deficits. Appearance, Mental Status was grossly normal, Speech and Movement, Mood and Affect was normal, Attitude was cooperative thought Process and Thought Content was normal, insight and Judgment was good. Smoking risk assessment was performed. Therapeutic measures were taken as a result of the events. At the time of this report, the outcome of event temperature was resolved on an unspecified date in 2021, breast tenderness was not resolved, and other events were resolving at the time of this report. Follow-up attempts are completed. No further information is expected.

Other Meds: MONTELUKAST SODIUM; ALLEGRA; FLONASE [FLUTICASONE PROPIONATE]; VITAMIN D NOS; FISH OIL; ALBUTEROL SULFATE; ASCORBIC ACID; CHOLECALCIFEROL; CLINDAMYCIN;TRETINOIN; CYANOCOBALAMIN; DIAZEPAM; EPINEPHRINE; FEXOFENADINE; METOPROLOL TARTRATE; OMEP

Current Illness: Allergy NOS; Anxiety (Medical History: Anxiety (Chronic)); Asthma (Medical History: Asthma (Chronic)); AV block first degree (Medical History: Mobitz (type) I (Wenckebach's) atrioventricular block); GERD (Medical History: GERD (gastroesophageal reflux disease)); Post-traumatic stress disorder (Medical History: PTSD (post-traumatic stress disorder))

ID: 1812838
Sex: F
Age:
State: PA

Vax Date: 06/01/2021
Onset Date: 06/02/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Low grade fever; Stomach ache; Depressed; Fatigue; Insomnia; This is a spontaneous report received from a contactable consumer. This consumer reported for a 12-year-old female patient. A 12-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: UNKNOWN), dose 1 intramuscular, administered in Arm Left on 01Jun2021 15:30 (at the age of 58-years-old) as a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was not pregnant at the time of vaccination. The patient had no other vaccine within four weeks and no other medications received within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02Jun2021 15:30, the patient experienced low grade fever, stomach ache, depressed, fatigue, insomnia. The patient received treatment with tylenol. No hospitalization prolonged. Outcome of the event was recovering, at the time of this report. Information about batch/lot number has been requested. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1812839
Sex: F
Age:
State: PA

Vax Date: 06/03/2021
Onset Date: 06/04/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Fever; chiils; vomiting; This is a spontaneous report from a contactable consumer (patient). A 14-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in Left arm on 03Jun2021 09:00 at the age of 14-years-old as dose 2, single for covid-19 immunisation at Pharmacy or Drug Store. The patient's medical history was not reported. Concomitant medications included cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) taken for an unspecified indication, start and stop date were not reported; fluticasone propionate (FLONASE [FLUTICASONE PROPIONATE]) taken for an unspecified indication, start and stop date were not reported received in two weeks of vaccination. The patient previously took first dose of historical vaccine, bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in Left leg on 13May2021 11:30 (at the age of 14-years-old) as single dose for covid-19 immunisation. The patient did not receive other vaccine in four weeks of vaccination. The patient was not diagnosed with COVID-19 prior vaccination. The patient has not been tested for COVID-19 post vaccination. On 04Jun2021 at 01:00, the patient experienced Fever, chills and vomiting. No treatment was received for adverse events. The outcome of events was recovering. Lot/batch number has been requested.

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE]; FLONASE [FLUTICASONE PROPIONATE]

Current Illness:

ID: 1812840
Sex: M
Age:
State: WA

Vax Date: 04/06/2021
Onset Date: 05/06/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210508; Test Name: RT-PCR; Test Result: Negative ; Comments: Nasal Swab

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: dry cough; Joints pain; red spots in the whole body; Fatigue; This is a spontaneous report from a contactable consumer (patient). A 47-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: ER8737, expiration date was not reported), via an unspecified route of administration, administered in left arm on 06Apr2021 17:00 (at the age of 47-years-old) as dose 2, single for covid-19 immunization. The patient medical history was none. Concomitant medication included isotretinoin (ACCUTANE) taken for unknown indication from an unknown date. Other medications the patient received within 2 weeks of vaccination included Accutane. The patient historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: EN6204, expiration date was not reported), via an unspecified route of administration, administered in left arm on 16Mar2021 12:00am (at the age of 47-years-old) as dose 1, single for covid-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient does not have any allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. It was reported that, on 06May2021 the patient experienced joints pain, red spots in the whole body, fatigue, dry cough. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included RT-PCR (sars-cov-2 test): negative on 08May2021 Nasal Swab. No treatment was received for the adverse events. Device date: 03Jun2021. The reporter assessed the seriousness as non-serious. The outcome of the events was not recovered. Follow-up attempts are completed. No further information is expected.

Other Meds: ACCUTANE

Current Illness:

ID: 1812841
Sex: F
Age:
State: CA

Vax Date: 05/14/2021
Onset Date: 05/18/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Name: Covid 19; Result Unstructured Data: Test Result:Positive; Comments: Prior to vaccination, was the patient diagnosed with COVID-19?: Yes

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Redness around left eyeball; Feel heaviness when I blink; Little pain; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old (non-pregnant) female patient received BNT162b2 (pfizer-biontech covid-19 mRNA vaccine; Lot Number: EW0168) dose 1 single via an unspecified route of administration in the arm left on 14May2021 at 18:00 ( age at vaccination 25-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any concomitant medications. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Medical history included COVID-19 positive. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18May2021, the patient experienced redness around left eyeball, feel heaviness when patient blink and little pain. The events resulted in doctor or other healthcare professional office/clinic visit. The patient underwent lab test included covid 19 was positive on an unknown date.Therapeutic measures were not taken as a result of these events. The clinical outcome of all the events was not recovered at the time of this report. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1812842
Sex: M
Age:
State: NJ

Vax Date: 05/16/2021
Onset Date: 05/17/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data: Test Date: 20210517; Test Name: Blood work; Result Unstructured Data: Test Result:Negative; Comments: Blood work for viral; Test Date: 20210517; Test Name: Fever; Result Unstructured Data: Test Result:100 to 103.5; Test Date: 20210517; Test Name: COVID-19; Result Unstructured Data: Test Result:Negative

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Every day my son is getting the fever with 100 to 103.5 after vaccination these 3 weeks; This is a spontaneous report from a contactable consumer. This consumer reported for male consumer (reporter's son) that, A 13-years-old male patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot Number: EW0185) (at the age of 13 years old), via an unspecified route of administration, administered in arm left on 16May2021 18:00 as dose number unknown, single for covid-19 immunisation. Medical history included blood iron decreased from an unknown date and unknown if ongoing and no known allergies. Concomitant medication(s) included paracetamol (TYNELOL) taken for an unspecified indication, start and stop date were not reported; ibuprofen (ADVIL) taken for an unspecified indication, start and stop date were not reported. It was reported that on 17May2021 every day patient was getting the fever with 100 to 103.5 after vaccination these three weeks. They had been conducted blood work for viral and Covid everything which was negative. But fever was not controlling. No treatment was received for event. Patient did not have covid prior to vaccination. The patient was visited, doctor or other healthcare professional office/clinic visit. Patient was not tested for covid post vaccination. The outcome for the event was not recovered. Follow-Up (19Jul2021): Follow-up attempts are completed. No further information is expected.

Other Meds: TYNELOL; ADVIL

Current Illness:

ID: 1812843
Sex: F
Age:
State: NY

Vax Date: 04/04/2021
Onset Date: 04/13/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: left arm pain and tingling; left arm pain and tingling; fevers; nausea; heaviness of her head; This is a spontaneous from a contactable physician reported that. A 64-years-old female patient received BNT162B2 (BioNTech/Pfizer vaccine solution for injection), dose 1 intramuscular, administered in Arm Left on 04Apr2021 (Batch/Lot Number: EW0169) as DOSE 1, SINGLE for covid-19 immunization (Age at vaccination 64 years). Facility where the most recent COVID-19 vaccine was administered: Hospital. The patient past medical history included hypertension from an unknown date and unknown if ongoing, Allergies to Chamomile, codeine, latex, mango, Pineapple and shellfish. The patient's concomitant medications were not reported. The patient previously took codeine and experienced drug hypersensitivity. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine within 4 weeks prior to covid-19 vaccination. The patient has not received other medications in two weeks. On 13Apr2021 the patient developed left arm pain and tingling, fevers, nausea and what she describes as heaviness of her head. The adverse event results Doctor or other healthcare professional office/clinic visit. The patient received a treatment with Pepcid. The event outcome was Not recovered. Device Date: 04Jun2021 Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1812844
Sex: F
Age:
State: CT

Vax Date: 05/01/2021
Onset Date: 05/01/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: first dose on 01May2021 and second dose on 01May2021; Body aches; back, neck and head pain; back, neck and head pain; back, neck and head pain/sharp head pain/headaches; Swelling periodically of thyroid area of neck; Subtle wheezing when laying on back in the evening; Random pains and cramping in arms (forearms and upper arms) not in area of vaccine arm. (Vaccine received in right arm, most pains/discomforts happening in left arm); Random pains and cramping in arms (forearms and upper arms) not in area of vaccine arm. (Vaccine received in right arm, most pains/discomforts happening in left arm); Random pains and cramping in arms (forearms and upper arms) not in area of vaccine arm. (Vaccine received in right arm, most pains/discomforts happening in left arm); This is a spontaneous report from a contactable consumer (patient) reporting for herself. A 26-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EW0185), via an unspecified route of administration, administered in Right arm on 01May2021 at the age of 26-years-old as dose 2, single for covid-19 immunisation. Medical history included Seasonal allergies, allergies to pollen, grass, and Asthma from unspecified date. Concomitant medication included naproxen (NAPROXEN) taken for an unspecified indication, start and stop date were not reported received within 2 weeks of vaccination. The patient previously took first dose of historical vaccine, bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EW0173), via an unspecified route of administration, administered in Right arm on 01May2021 11:00 at the age of 26-years-old as single dose for covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient has not been tested for COVID-19 since the vaccination. Device Date: 04Jun2021. On an unspecified date in 2021, the patient experienced Body aches, back, neck and head pain noticeable 1-2 weeks after second dose. Swelling periodically of thyroid area of neck, sharp head pain/headaches. Subtle wheezing when laying on back in the evening. Random pains and cramping in arms (forearms and upper arms) not in area of vaccine arm. Vaccine received in right arm, most pains/discomforts happened in left arm. It was reported that it was not an immediate reaction. No anaphylactic shock from doses. Adverse events resulted in Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. It was unknown if the patient received treatment for adverse events. The outcome of events, Body aches, back, neck and head pain/sharp head pain/headaches, Swelling periodically of thyroid area of neck, Subtle wheezing, Random pains and cramping in arms (forearms and upper arms) not in area of vaccine arm, most pains/discomforts happening in left arm was not recovered. Follow-up attempts are completed. No further information is expected.

Other Meds: NAPROXEN

Current Illness:

ID: 1812845
Sex: F
Age:
State: NY

Vax Date: 06/04/2021
Onset Date: 06/05/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Fever; Chills; Body aches; Intense pain at injection site; Sever shaking; Rapid breathing; Radiating pain throughout whole body, decreased strength; Headache; Fatigue; This is a spontaneous report from a contactable consumer (patient herself). A 15-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: ew0180; Expiration date: unknown) via an unspecified route of administration, administered in Arm Left on 04Jun2021 17:00 (at the age of 15-years-old) as DOSE 2, SINGLE for COVID-19 immunization. Patient was not pregnant at the time of vaccination. The patient medical history and concomitant medications were not reported. The patient previously took amoxicillin and experienced drug hypersensitivity. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: ew0177; Expiration date: unknown) via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for COVID-19 immunization. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. On 05Jun2021 06:00 patient experienced fever, chills, body aches, intense pain at injection site, severe shaking, rapid breathing, radiating pain throughout whole body, decreased strength, headache and fatigue. Patient did not receive any treatment for adverse event. Since the vaccination, patient has not been tested for COVID-19. The outcome of all events was not recovered. Follow-Up (27Jul2021): Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1812846
Sex: M
Age:
State: CA

Vax Date: 06/03/2021
Onset Date: 06/05/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: my injected arms' lymph is swollen; fatigue; fever; This is a spontaneous report from a contactable consumer. This consumer (patient) reported for self that, A 47-years-old male patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot Number: EW0187) (at the age of 47 years old), dose 2 via an unspecified route of administration, administered in arm left on 03Jun2021 09:00 as dose 2, single for covid-19 immunisation in hospital. Historical vaccine, the patient took first dose bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot number: EW0170), dose 1 via an unspecified route of administration, administered in arm left on 13May2021 09:00 as dose 1, single for covid-19 immunisation. Medical history included blood cholesterol increased from an unknown date and unknown if ongoing, food allergy from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. It was reported that six hours after he took the second dose, on 05Jun2021 08:00 he started feeling fatigue and fever. In last 48 hours and then, after that he realized that his injected arm lymph was swollen. This was the first time he noticed the reaction after getting any kind of vaccines or injection. No treatment for events was received. Patient did not have covid prior to vaccination. He was not tested for covid post vaccination. The outcome for the events was not recovered. Follow-Up (04Aug2021): Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1812847
Sex: F
Age:
State: MD

Vax Date: 06/04/2021
Onset Date: 06/05/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data: Test Date: 20210605; Test Name: fever; Result Unstructured Data: Test Result:104.2 Fahrenheit; Comments: Fever 104.2 F; Test Date: 20210605; Test Name: heart rate; Result Unstructured Data: Test Result:126; Test Date: 20210603; Test Name: Applied biosystems 7500 real-time PCR; Test Result: Negative ; Comments: Nasal Swab

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: On the morning after the 2nd dose had Fever 104.2 F; heart rate 126; vomiting; fatigue; mottled/bluish fingers and lips; mottled/bluish fingers and lips; This is a spontaneous report from a contactable consumer (patient). A 12-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EW0191), via an unspecified route of administration, administered in Right arm on 04Jun2021 13:15 at the age of 12-years-old as dose 2, single for covid-19 immunisation. Medical history included Von Willebrand Disease from an unknown date. The patient had no known allergies. Concomitant medication included ethinylestradiol, norgestrel (CRYSELLE) taken for an unspecified indication, start and stop date were not reported received in two weeks of vaccination. The patient previously took first dose of historical vaccine, bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EW0183), via an unspecified route of administration, administered in Right arm on 14May2021 13:00 at the age of 12-years-old as single dose for covid-19 immunisation. The patient did not receive other vaccine in four weeks of vaccination. The patient was not diagnosed with COVID-19 prior vaccination. The patient has been tested for COVID-19 post vaccination. On 05Jun2021 at 06:00, in the morning the patient experienced after the 2nd dose had Fever 104.2 F, heart rate 126, vomiting, fatigue and mottled/bluish fingers and lips. Adverse events resulted in Emergency room/department or urgent care. The patient received treatment for adverse events with IV fluids. The patient underwent lab tests and procedures which included heart rate: 126 on 05Jun2021, fever (Body temperature): 104.2 fahrenheit fever on 05Jun2021, Applied biosystems 7500 real-time PCR (Nasal Swab) (sars-cov-2 test): negative on 03Jun2021. The outcome of events was recovering. Follow-up attempts are completed. No further information is expected.

Other Meds: CRYSELLE

Current Illness:

ID: 1812848
Sex: F
Age:
State: LA

Vax Date: 05/21/2021
Onset Date: 05/28/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: I have a rash, that start 28May. It really only flare up in the morning when I wake up and at night before going to bed; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: ER8736), via an unspecified route of administration, administered in arm left on 21May2021 15:30 as dose 1, single (at the age of 37-year-old) for covid-19 immunization. The patient was non-pregnant at the time of vaccination. Medical history reported as none. There were no known allergies. Concomitant medication included mepyramine maleate, pamabrom, paracetamol (PAMPRIN). On 28May2021 06:00, the patient experienced rash. It really only flares up in the morning when she wakes up and at night before going to bed. It started on her hands, then ankles now it was on her arms, neck and face. The patient did not receive any treatment for the events. The patient did not received any other vaccine in four weeks. The patient had not covid prior to the vaccination and patient had not tested for covid post vaccination. The outcome of the event was not recovered. Follow-up attempts were completed. No further information was expected.

Other Meds: PAMPRIN

Current Illness:

ID: 1812849
Sex: F
Age:
State: IL

Vax Date: 06/04/2021
Onset Date: 06/04/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Swelled throat; rash; Feeling cold; mucus along with swollen neck and throat; mucus along with swollen neck and throat; This is a spontaneous report from a contactable consumer (patient). A 15-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: ER8731, patient was not pregnant at the time of vaccination), via an unspecified route of administration, administered in Arm Left on 04Jun2021 at 08:30 (at the age of 15-year-old) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included vitiligo. There were no concomitant medications. No other vaccine received in four weeks, no other medications received in two weeks, no covid prior vaccination, no covid tested post vaccination, no Known allergies were reported. On 04Jun2021 at 12:00, the patient experienced swelled throat, rash, feeling cold, mucus along with swollen neck and throat, mucus along with swollen neck and throat. No treatment was received for events. Reported that event swelled throat still not gone to normal after 48 hours. The outcomes of events (swelled throat, feeling cold, mucus along with swollen neck and throat, mucus along with swollen neck and throat) were not recovered and the outcome of event (rash) was recovered on 05Jun2021 (after 24 hours). Follow-Up (19Jul2021 and 05Aug2021): Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1812850
Sex: F
Age:
State: CA

Vax Date: 05/17/2021
Onset Date: 05/19/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data: Test Date: 20210519; Test Name: Fever; Result Unstructured Data: Test Result:103.6

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Fever 103.6; Chills; Nausea; Dizzy, couldn't drive because I was so dizzy; Exhausted; Headache; Aching all over; This is a spontaneous report from a contactable consumer (patient) reporting for herself. A 54-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EN6199, Expiry date: unknown), via an unspecified route of administration, administered in left shoulder of left arm on 17May2021 at 10:30 AM as dose 1, single for COVID-19 immunization at public health clinic/administration facility. Medical history included Bells palsy and allergy to walnuts, mold and fungus. There were no concomitant medications. Patient was not pregnant at vaccination. Patient did not test for covid prior vaccination. Patient did not get covid tested post vaccination. Patient did not take other vaccine in four weeks. No other medications in two weeks. On 19May2021, she experienced fever 103.6, chills, nausea, dizzy, she couldn't drive because she was so dizzy, exhausted, headache, aching all over. Patient did not take any treatment. Patient underwent lab data and procedure which included Body temperature 103.6 on 19May2021. Outcome of all events was recovered in 2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1812851
Sex: M
Age:
State: KY

Vax Date: 05/15/2021
Onset Date: 06/05/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210605; Test Name: fever; Result Unstructured Data: Test Result:100.5

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Chills; arm pain; fever 100.5; diarrhea; This is a spontaneous report from a contactable consumer or other non healthcare professional. A male patient of an unspecified age received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Right on 15May2021 04:30 (Batch/Lot Number: EW0179) as DOSE 1,SINGLE, dose 2 via an unspecified route of administration, administered in Arm Right on 15May2021 (Batch/Lot Number: EW0172) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included asthma from an unknown date and unknown if ongoing, hypersensitivity from an unknown date and unknown if ongoing Allergic to green beans and nuts. Concomitant medication(s) included beclometasone dipropionate (QVAR) taken for an unspecified indication, start and stop date were not reported; cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) taken for an unspecified indication, start and stop date were not reported. The patient experienced chills on 05Jun2021 17:45 with outcome of not recovered, arm pain causing pain in extremity on 05Jun2021 17:45 with outcome of not recovered, fever 100.5 causing pyrexia on 05Jun2021 17:45 with outcome of not recovered, diarrhoea on 05Jun2021 17:45 with outcome of not recovered. The patient underwent lab tests and procedures which included body temperature:at 100.5 on 05Jun2021. Therapeutic measures were taken as a result of these events. Follow-up(27Jul2021):This is a Follow-up spontaneous report from a contactable consumer. This consumer reported in response to Non HCP letter sent that included: No information can be released on this person. Follow-up attempts are completed. No further information is expected.

Other Meds: QVAR; ZYRTEC [CETIRIZINE HYDROCHLORIDE]

Current Illness:

ID: 1812852
Sex: F
Age:
State: FL

Vax Date: 03/16/2021
Onset Date: 03/01/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: strong pain/pangs in chest at middle of the night; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 64-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6198, Expiry date: unknown), via an unspecified route of administration, administered in arm left on 16Mar2021 (at the age of 64 years old) as dose 1, single for covid-19 immunisation. Medical history included mitral valve prolapse, allergies, Known allergies: yes, Seasonal allergy, and low blood pressure. The concomitant medications were not reported. The patient was not pregnant at the time of vaccination. The patient also received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EN6208, Expiry date: unknown), via an unspecified route of administration, administered in arm left on 06Apr2021 as dose 2, single for covid-19 immunisation and experienced similar events on 06Apr2021. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any treatment for the event. The patient experienced strong pain/pangs in chest at middle of the night on Mar2021. Since then, she had chest pains/soreness/pangs, what she thought was myocarditis. The outcome of the events was not recovered. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1812853
Sex: F
Age:
State: FL

Vax Date: 06/04/2021
Onset Date: 06/05/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: I am bruising *very* easily, with just moderate pressure against my skin (arms, legs, hands, feet, torso).; This is a spontaneous report from a contactable consumer (patient) reported for herself that. A 59-years-old non-pregnant female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Right on 04Jun2021 11:00 (Batch/Lot Number: EW0171) as DOSE 2, SINGLE for covid-19 immunization (Age at vaccination 59 years). Facility type vaccine: Pharmacy or Drug Store. The patient past medical history included osteoarthritis from an unknown date and unknown if ongoing and Acid reflux from an unknown date and unknown if ongoing. Concomitant medication(s) included naproxen (NAPROXEN, 5 days prior) taken for an unspecified indication, start and stop date were not reported; omeprazole (OMEPRAZOLE, daily) taken for an unspecified indication, start and stop date were not reported. The patient previously took tetanus toxoid and experienced drug hypersensitivity and bnt162b2 dose 1 via an unspecified route of administration, administered in Arm Right on 14May2021 10:30 am (Batch/Lot Number: EW0179) as DOSE 2, SINGLE for covid-19 immunization. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine within 4 weeks prior to covid-19 vaccination. On 05Jun2021, The patient experienced bruising very easily, with just moderate pressure against my skin (arms, legs, hands, feet, torso). No treatment was received. The event outcome was not recovered. Follow-up attempts are completed. No further information is expected

Other Meds: NAPROXEN; OMEPRAZOLE

Current Illness:

ID: 1812854
Sex: F
Age:
State: CA

Vax Date: 05/10/2021
Onset Date: 05/12/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210514; Test Name: Nasal Swab; Test Result: Negative ; Comments: Nasal Swab

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: hardness at injection sight.; May 12, 13, 14, 15 bone and muscle aches all over; May 12, 13, 14, 15 bone and muscle aches all over; intermittent fever; no energy; This is a spontaneous report received from a contactable Other HCP (Nurse). This 57-year-old non-pregnant female Nurse (patient herself) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: EWD176; Expiration date: unknown) via an unspecified route of administration, administered in Arm Left on 10May2021 17:00 (at the age of 57-years-old) as DOSE 1, SINGLE for COVID-19 immunization. Patient was not pregnant at the time of vaccination. The patient medical history was not reported. Concomitant medication included fluoxetine (FLUOXETINE) taken for an unspecified indication. The patient previously took erythromycin and experienced drug hypersensitivity. On 12May2021 22:00 the patient experienced hardness at injection sight, may 12, 13, 14, 15 bone and muscle aches all over, intermittent fever and no energy. Patient did not receive any treatment for adverse event. The patient underwent lab tests and procedures which included SARS-COV-2 antibody test (Nasal Swab) negative on 14May2021 post the vaccination. The outcome of event hardness at injection sight was resolved on an unspecified date in 2021 while all other events was resolved on 15May2021. Follow-Up (12Jul2021): Follow-up attempts are completed. No further information is expected.

Other Meds: FLUOXETINE

Current Illness:

ID: 1812855
Sex: F
Age:
State: WA

Vax Date: 05/01/2021
Onset Date: 05/07/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: I broke out with a heat rash and hives on both sides of my neck and both wrists.; I broke out with a heat rash and hives on both sides of my neck and both wrists.; This is a spontaneous report from a contactable consumer (Patient). An adult non-pregnant female patient of an unspecified age (current age reported as 44-year-old) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: EW0168, and Expiration date: Unknown), via an unspecified route of administration, administered in left arm on an unspecified date in May2021 at 10:00 AM as dose 2, single for COVID-19 immunization. The patient medical history included gout, factor five Leiden syndrome, and calcium deposits. The patient received unspecified concomitant medications. The patient previously took VIT E [tocopherol] and experienced drug hypersensitivity. Previously the patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: EW0153, and Expiration date: Unknown), via an unspecified route of administration, administered in left arm on an unspecified date in Apr2021at 07:00 AM as dose 1, single for COVID-19 immunization. The patient received other vaccine on an unspecified date in May2021. No other vaccine in four weeks. The patient had no COVID prior vaccination. The patient was not tested for COVID post vaccination. The patient reported that, on 07May2021 03:00 AM, two days after receiving second COVID shot, "I broke out with a heat rash and hives on both sides of my neck and both wrists". It continued today, a month after her 2nd shot was administered. The patient visited her naturopath, tried to schedule an appointment. The patient took unspecified treatment for the events. The outcome of the events was reported as not resolved. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1812856
Sex: F
Age:
State: KY

Vax Date: 06/03/2021
Onset Date: 06/04/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210604; Test Name: Fever; Result Unstructured Data: Test Result:ranging from 100.7 to 101.5

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: vomiting/threw up multiple times; nauseas for 12 plus hours; had a fever ranging from 100.7 to 101.5; This is a spontaneous report from a contactable consumer (Parent of patient). A 13-years-old non pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: EW0178, Expiry date: not reported), via intramuscular route of administration in left arm on 03Jun2021 16:00 (at age of 13-years-old) as dose 2, single for covid-19 immunization in Doctor's office/Urgent Care. Medical history included thin basement membrane disease (Ongoing monitoring, no surgery), vitamin d deficiency and penicillin allergy. Concomitant medication(s) included colecalciferol (VITAMIN D [COLECALCIFEROL]) taken for vitamin d deficiency from 05May2021 and ongoing, colecalciferol (REPLESTA) taken for vitamin d deficiency from 05May2021 and ongoing. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: EW0161, Expiration Date: Not reported), via intramuscular route of administration in left arm on 13May2021 16:00 (at age of 13-years-old) as dose 1, single for covid-19 immunization. The patient had not received any prior vaccinations. Prior to vaccination, the patient was not diagnosed with COVID-19 and post the vaccination, the patient was not tested for COVID-19. The caller reported that about 14 hours after the patient received the second covid shot (04Jun2021 at 04:00), the patient began vomiting. The patient threw up multiple times. The reporter estimated that the patient vomited about 4 times. The patient was nauseas for 12 plus hours and had a fever ranging from 100.7 to 101.5. The reporter assessed the events as non-serious. The patient underwent lab tests and procedures which included pyrexia: ranging from 100.7 to 101.5 on 04Jun2021. No relevant tests were performed. No therapeutic measures were taken in response to the events. The events recovered on an unspecified date in 2021 (patient had fully recovered). Follow-up attempts are completed. No further information is expected.

Other Meds: VITAMIN D [COLECALCIFEROL]; REPLESTA

Current Illness: Nephropathy; Vitamin D deficiency

ID: 1812857
Sex: F
Age:
State: PA

Vax Date:
Onset Date: 05/15/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Patient developed rash on both arms 3 days after the vaccination. It lasted for 2 weeks.; This is a spontaneous report from a contactable consumer (parent). A 14-years-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN5318), via an unspecified route on unspecified date (at the age of 14-years) as dose 1, single in the left arm for covid-19 immunisation. The patient medical history included Known allergies: penicillin and some sunscreens. The patient concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within 2 weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced rash on both arms 3 days after the vaccination on 15May2021. It lasted for 2 weeks. Patient did not received treatment for events. The outcome of the events was recovered on May2021. Information on Lot/Batch number was available. Additional information has been requested Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1812858
Sex: F
Age:
State: PA

Vax Date: 06/02/2021
Onset Date: 06/02/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: she developed a rash on on her arm and chest within 2 hours of the shot; This is a spontaneous report from a contactable consumer (patient's mother). A 14-year-old female patient (reporter's daughter) received second dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EW0185 and expiry date was not reported), via an unspecified route of administration, on 02Jun2021 (age vaccination: 14 years), as dose 2, single dose for COVID-19 immunization. The patient was not pregnant at the time of vaccination. The patient's medical history included Penicillin allergy. Concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EN5318 and expiry date was not reported), via an unspecified route of administration, in Arm Left, on an unspecified date, as dose 1, single dose for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID prior vaccination. The patient was not tested for COVID Since the vaccination. The patient developed rash on both arms 3 days after the vaccination. It lasted for 2 weeks. Her 2nd vaccination was on 02Jun2021, and she developed a rash on on her arm and chest within 2 hours of the shot. The rash persists. The patient took Zyrtec and rash lessens with Zyrtec. Outcome of the event was recovering. Information on Lot/Batch number was available. Additional information has been requested. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1812859
Sex: F
Age:
State: MD

Vax Date: 06/04/2021
Onset Date: 06/05/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Left arm, leg, back went numb tingling for a day intense pain, hives on face, lump in armpit lymph node still there; Left arm, leg, back went numb tingling for a day intense pain, hives on face, lump in armpit lymph node still there; Left arm, leg, back went numb tingling for a day intense pain, hives on face, lump in armpit lymph node still there; Left arm, leg, back went numb tingling for a day intense pain, hives on face, lump in armpit lymph node still there; Left arm, leg, back went numb tingling for a day intense pain, hives on face, lump in armpit lymph node still there; Left arm, leg, back went numb tingling for a day intense pain, hives on face, lump in armpit lymph node still there; Left arm, leg, back went numb tingling for a day intense pain, hives on face, lump in armpit lymph node still there; Left arm, leg, back went numb tingling for a day intense pain, hives on face, lump in armpit lymph node still there; Left arm, leg, back went numb tingling for a day intense pain, hives on face, lump in armpit lymph node still there; Left arm, leg, back went numb tingling for a day intense pain, hives on face, lump in armpit lymph node still there; This is a spontaneous report from a contactable consumer or other non-healthcare professional (Patient) reported for herself. A 52-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EW0191), second dose via an unspecified route of administration, administered in left arm on 04Jun2021 at 17:00 (at the age of 52-year-old) as dose 2, single for COVID-19 immunisation at pharmacy or drug store. Medical history included Lyme disease from an unknown date and unknown if ongoing. No known allergies were reported. Concomitant medications included valaciclovir hydrochloride (VALTREX) taken for an unspecified indication, start and stop date were not reported. Historical vaccine given to patient previously was bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EW0183), first dose via an unspecified route of administration, administered in left arm on 15May2021 at 09:15 (at the age of 52-year-old) as dose 1, single for COVID-19 immunisation at pharmacy or drug store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received other vaccines within 2 weeks of COVID vaccine included Valtrex. The patient did not diagnose with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. The patient experienced left arm, leg, back went numb tingling for a day intense pain, hives on face, lump in armpit lymph node still there on 05Jun2021 at 03:00. No treatment was received for the events. The outcome of the events was reported as resolving. Follow-up attempts are completed. No further information is expected.

Other Meds: VALTREX

Current Illness:

ID: 1812860
Sex: M
Age:
State: IL

Vax Date: 06/04/2021
Onset Date: 06/05/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210605; Test Name: temperature; Result Unstructured Data: Test Result:101; Test Date: 20210606; Test Name: temperature; Result Unstructured Data: Test Result:97

Allergies:

Symptom List: Nausea

Symptoms: Eyes was slightly swollen,trouble opening his eyelash; Temperature was around 101 degree; This is a spontaneous report from a contactable consumer. A 12-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number and Expiry date was not reported), via an unspecified route of administration, administered in Arm Left on 04Jun2021 17:30 (at the age of 12 years old) as dose 2, single for COVID-19 immunization. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number EW0175), via an unspecified route of administration, administered in Arm Left on 14May2021 17:30 as dose 1, single for COVID-19 immunization. The consumer stated lot number for 2nd dose, It is EW0185 I don't know its 5 or S. I think it is muscular they did not find any veins I believe because it was in the top part of the left arm is where they gave here the shoulder so I think it is muscular. The patient medical history was not reported. There was no family medical history. There were no concomitant medications. My son who is 12 years old got the second dose of Pfizer vaccine on Friday evening which is 04Jun and he had a temperature on Saturday, 05Jun and his temperature was around 101 degree and we gave him Tylenol (treatment), 2 dose, one was on Friday evening other one was on Saturday morning and he took the third dose on Saturday night as well and the issue is when he woke up morning on Sunday 06Jun his eyes was slightly swollen and we just wanted to report that would be a possible side effect of taking the vaccine but currently he doesn't have any body temperature, he is normal at 97 degree and he doesn't have any breathing related issue, we just wanted to report about his swollen eyes. And he has swollen eyes and that's the main concern for me and you know for him it's like he has trouble opening his eyelash, but he is feeling normal right now, no breathing related issue. He doesn't have any fever or temperature. For swollen eyes we gave him Claritin (treatment) and we are observing him. All doses of 10ml for both Tylenol and Claritin. The patient underwent lab tests and procedures which included body temperature: 101 on 05Jun2021, body temperature-97 on 06Jun2021.Therapeutic measures were taken as a result of temperature was around 101 degree and eyes was slightly swollen, trouble opening his eyelash. The outcome of event was unknown for eyes was slightly swollen, trouble opening his eyelash. The outcome of event was recovering for experienced temperature was around 101 degrees. This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected

Other Meds:

Current Illness:

ID: 1812861
Sex: M
Age:
State: OR

Vax Date: 06/02/2021
Onset Date: 06/05/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Rash covering the torso, front and back. Not noticed until 6/5/21; This is a spontaneous report from a contactable consumer or other non-HCP (patient himself). A 12-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EW0191) via an unspecified route of administration, administered in left arm on 02Jun2021 at 09:45 AM, as DOSE 2, SINGLE (at the age of 12-year-old) for COVID-19 immunization. The patient medical history reported as none. The concomitant medications were not reported. Patient had no known allergies. Historical vaccine includes BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EW0172) via an unspecified route of administration in left arm on 12May2021 at 12:00 PM, as DOSE 1, SINGLE (at the age of 12 years-old) for COVID-19 immunization. No other vaccine in four weeks. No covid prior vaccination and not tested for covid post vaccination. The patient experienced rash covering the torso, front and back, not noticed until 6/5/21 on 05Jun2021. No treatment received for the events. The outcome of the event was resolving at the time of this report. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1812862
Sex: F
Age:
State: WA

Vax Date: 06/04/2021
Onset Date: 06/05/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210605; Test Name: Low grade temp 99.2; Result Unstructured Data: Test Result:99.2; Comments: Low grade Temp 99.2

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Low grade temp 99.2; Extreme arm discomfort.; Pounding headache.; Extreme tiredness; Body aches; This is a spontaneous report from a contactable consumer (patient). A 35-years-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EW0185), via an unspecified route of administration, administered in right arm on 04Jun2021 at 19:15 PM (Age at Vaccination 35-years-old) as dose 2, single for Covid-19 immunization at Pharmacy or Drug Store. Medical history included allergies with latex, Benadryl, bee venom. Concomitant medications were not reported. Patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EW0173) via an unspecified route of administration, administered in right arm on 14May2021 at 19:45 PM (Age at Vaccination 35-years-old) as dose 1, single for Covid-19 immunization. Patient did not take any prior Covid vaccination, and she did not get tested for Covid post vaccination. On 05Jun2021 patient experienced Extreme arm discomfort, pounding headache, extreme tiredness, body aches and low-grade temp 99.2, she did not take any treatment and no other medications in 2 weeks. The patient underwent lab data and procedure which include Body temperature abnormal Low-grade Temp 99.2 on 05Jun2021. Outcome of all events was recovering. Follow-Up (26Jul2021): Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1812863
Sex: M
Age:
State: CT

Vax Date:
Onset Date: 05/01/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: fever; chills; vomiting; This is a spontaneous report from a non-contactable Other HCP. This Other HCP reported for a 13-year-old Male patient that: A 13-years-old male patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: was not reported), intramuscular on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. No known allergies. It was unknown, the patient receive any other vaccines within 4 weeks prior to the COVID vaccine and whether the patient received other medications within 2 weeks of vaccination. On unspecified date in May202, the patient had experienced fever, chills and vomiting. It was unknown if the patient received treatment in response to the adverse events. It was unknown, the patient was covid prior vaccination or if covid tested post vaccination. On an unspecified date in 2021, the events were recovered. Follow-up attempts are completed. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1812864
Sex: F
Age:
State: FL

Vax Date: 04/03/2021
Onset Date: 05/06/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Strong joint pain in right arm at the elbow, upper shoulder blade and collarbone.; Pain has subsided, but still feeling the effects; unable to lie down on my right side or lift/carry light; This is a spontaneous report from a contactable consumer and other non-health care professional. A 68-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: ER2613, Expiry date not reported) via an unspecified route of administration, administered in right arm on 03Apr2021 at 12:15 (at age of 68-years-old) as dose 2, single for COVID-19 immunisation. Medical history include Spinal osteoarthritis and Covid-19. There are no known allergies. Patient did not receive any other medication within two weeks. The patient was diagnosed with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. Patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE,Solution for injection, Lot Number: EN6199, Expiry date not reported) via an unspecified route of administration, administered in Right arm on 13Mar2021 (at age of 68-years-old) as single dose for COVID-19 immunisation. On 06May2021 at 05:00 (1 month 2 days 16 hrs 45 min after vaccination), Patient experienced strong joint pain in right arm at the elbow, upper shoulder blade and collarbone. Pain has subsided, but still feeling the effects. I am unable to lie down on my right side or lift/carry light items. If I do, I experience the pain. Patient did not receive any treatment for the events. The Outcome of the events was recovering. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1812865
Sex: M
Age:
State: HI

Vax Date: 05/15/2021
Onset Date: 05/16/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: body aches; horrible pounding migraine that lasted 2 days for 1st dose; 24 hours after injection I have gotten a 102F+ fever; uncontrollable body chills; This is a spontaneous report from a contactable consumer (patient). A 35-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Formulation: Solution for injection, Lot number: EW0168) via an unspecified route of administration on 15May2021 at 01:00 PM on left arm as dose 1, single (Age at vaccination: 35-year-old) for Covid-19 immunization. The patient did not receive any other vaccine in four weeks of Covid-19 vaccine. The patient has no known allergies. The patient was neither had Covid 19 prior vaccination nor tested post vaccination. Medical history included disability due to back injury and nerve damage in both legs. Concomitant medications included: Buprenorphine, Oxycodone, Etodolac, and Baclofen (in two weeks of Covid-19 vaccine). 24 hours after injection (on 16May2021), the patient had gotten a 102F+ fever, uncontrollable body chills, body aches, horrible pounding migraine that lasted 2 days for 1st dose. The patient did not receive any treatment for adverse events. The patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Formulation: Solution for injection, Lot number: EW0187) on 05Jun2021 at 01: 00 pm on right arm as dose 2, single for Covid-19 immunization. Outcome of migraine was recovered on an unspecified date in May2021, and other events were recovered on an unspecified date. Follow-up attempts are completed. No further information is expected.

Other Meds: BUPRENORPHINE; OXYCODONE; ETODOLAC; BACLOFEN

Current Illness:

ID: 1812866
Sex: F
Age:
State: IL

Vax Date: 05/22/2021
Onset Date: 05/24/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data: Test Name: Blood test; Result Unstructured Data: Test Result:Unknown result; Test Name: cardiac scan; Result Unstructured Data: Test Result:Unknown result; Test Name: xray; Result Unstructured Data: Test Result:Unknown result

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Chest pain; left arm pain; left hand numbness; back pain; This is a spontaneous report from a contactable consumer or other non-health care professional (Patient). A 36-years-old non-pregnant female patient received bnt162b2 (COMIRNATY, PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection and Batch no: not reported/Lot number: EW0178) via unspecified route of administration administered in arm left on 22May2021 02:00 PM (at the age of 36-years-old) as dose 1, single for covid-19 immunization at Pharmacy or Drug Store. Medical history and concomitant medications were none. Known allergies were reported as no. No covid prior vaccination and not tested for covid post vaccination. No other vaccines taken within four weeks and no other medications in two weeks. On 24May2021 12:00 AM, patient experienced with chest pain, left arm pain, back pain, left hand numbness. No relief since more than 2 weeks. AE resulted in Emergency room/department or urgent care, which causes patient went to Emergency in (hospital name) for 8 hrs. On an unspecified date, patient underwent lab tests and procedures which included Blood test, X-ray and cardiac scan with unknown results all. No relief in symptoms. No treatment AE received for the events caused. Outcome of the events was not recovered. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1812867
Sex: M
Age:
State: AZ

Vax Date: 02/01/2021
Onset Date: 03/08/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: feel this is some sort of allergic reaction; began to develop itchy, sore welts; began to develop itchy, sore welts; I developed a persistent itch on both of my hands on the skin between my thumb and fore finger.; Within 9 days of the 2nd dose I began to develop itching lumps on the back of my head approximately 1 inch above my hair line.; Within 9 days of the 2nd dose I began to develop itching lumps on the back of my head approximately 1 inch above my hair line.; This is a spontaneous report from a contactable consumer or other non-healthcare professional (patient). A 61-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EL3248), second dose via an unspecified route of administration, administered in right arm on an unspecified date in Feb2021 at 14:00 as dose 2, single for COVID-19 immunisation. Medical history included hypertension from an unknown date and unknown if ongoing, blood cholesterol increased from an unknown date and unknown if ongoing, drug hypersensitivity from an unknown date and unknown if ongoing Sufla related drugs. Historical vaccine given to patient previously was bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EL8982), first dose via an unspecified route of administration, administered in right arm on an unspecified date in 04Feb2021 at 08:30 as dose 1, single for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received unspecified medications within 2 weeks of COVID vaccine. The patient did not diagnose with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. The patient experienced within 9 days of the 2nd dose I began to develop itching lumps on the back of my head approximately 1 inch above my hair line on 08Mar2021 at 20:00, I developed a persistent itch on both of my hands on the skin between my thumb and fore finger on 12Mar2021, began to develop itchy, sore welts on 17Mar2021. It was reported that, within 9 days of the 2nd dose, I began to develop itching lumps on the back of my head approximately 1 inch above my hair line. On 12Mar2021 I developed a persistent itch on both of my hands on the skin between my thumb and fore finger. On 17Mar2021 I began to develop itchy, sore welts on about 45% of my body. On an unspecified date, the Doctors, ER and others feel this is some sort of allergic reaction. Prior to receiving the vaccine my only allergy was to Sulfa type drugs. Adverse events resulted in doctor or other healthcare professional office/clinic visit emergency room/department or urgent care. Adverse events treatment included IV therapy and ongoing Prednisone. The outcome of all the events was reported as not resolved and outcome of the event feel this is some sort of allergic reaction was unknown. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1812868
Sex: F
Age:
State: IN

Vax Date: 06/02/2021
Onset Date: 06/06/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210604; Test Name: COVID test (rapid); Test Result: Negative ; Comments: Nasal Swab

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: slightly raised itchy bright pink rash starting on chest spreading to L side of neck.; slightly raised itchy bright pink rash starting on chest spreading to L side of neck.; slightly raised itchy bright pink rash starting on chest spreading to L side of neck.; itch scalp and arms; This is a spontaneous report from a contactable Nurse (patient) reported for herself. A 53-years-old female patient (patient was not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: ew0176, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 02Jun2021 at 19:30 pm (age at vaccination was 53 years) as dose 1, single for COVID-19 immunization. The patient's medical history was not reported. The patient did not have any known allergies. Concomitant medication the patient received in two weeks included multi vitamin. The facility where the most recent COVID-19 vaccine was administered was Pharmacy or Drug Store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient underwent lab test which included COVID test (rapid, nasal swab): negative on 04Jun2021. On 06Jun2021 at 21:00 pm, the patient experienced slightly raised itchy bright pink rash, starting on chest spreading to L side of neck also noted on fingers and lower extremities, itch scalp and arms. No treatment was received for the adverse events. The outcome of the events was unknown. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1812869
Sex: M
Age:
State: NY

Vax Date: 06/05/2021
Onset Date: 06/06/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: fever at above 102 degrees F; Chills; lethargy; This is a spontaneous report from a contactable consumer. This consumer reported for a 13-year-old male patient that: A 13-years-old male patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EW0167), intramuscular, administered in Arm Left on 05Jun2021 12:00PM (At the age of 13 years) as DOSE 2, SINGLE for covid-19 immunisation. The patient previously received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EW0167), intramuscular, administered in Arm Left on 15May2021 05:00PM (At the age of 13 years) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history was not reported. No known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient's concomitant medications were not reported. The patient did not receive other medications within 2 weeks of vaccination. On 06Jun2021 09:00AM, the patient experienced fever at above 102 degrees, chills and lethargy. No treatment was received in response to the adverse events. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient was not tested for COVID-19. At the time of reporting, the outcome of the events were unknown. Follow-up attempts are completed. No further information is expected

Other Meds:

Current Illness:

ID: 1812870
Sex: F
Age:
State: VA

Vax Date: 05/11/2021
Onset Date: 05/26/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: headache; itching; hives on my lower back and shoulders; swelling of my face especially around eyes and lips; swelling of my face especially around eyes and lips; swelling of my face especially around eyes and lips; This is a spontaneous report from a contactable consumer. This 62-year-old female consumer reported for herself. A 62-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: EW0182), dose 1 via an unspecified route of administration, administered in Arm Left on 11May2021 17:00 (at the age of 62-years-old) as a single dose for covid-19 immunization. Medical history included dermal filler injection from Aug2020 to an unknown date. Concomitant medication(s) in two weeks included phyllanthus emblica, terminalia bellirica, terminalia chebula (TRIPHALA); vitamin d3; curcuma longa (TURMERIC [CURCUMA LONGA]); magnesium; ammonium chloride, betaine hydrochloride, pancreas extract, pancreatin, pepsin, spleen, stearic acid (ZYPAN). The patient had no other vaccine within four weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 26May2021 06:00, the patient awoke on Day 21 with headache and itching. Realized she had hives on her lower back and shoulders. When she looked in mirror, noticed swelling of face especially around eyes and lips. Adverse event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment. Outcome of the event was recovered on an unspecified date in 2021, at the time of this report. Follow-up attempts are completed. No further information is expected.

Other Meds: Triphala; Vitamin D3; Turmeric [Curcuma Longa]; Magnesium; Zypan

Current Illness:

ID: 1812871
Sex: M
Age:
State: PA

Vax Date: 06/01/2021
Onset Date: 06/02/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Also on the right anterior neck area; Ear pain; Developed right neck and scalp rash; Burning; Swelling; About 5 minutes after injection, got a temporary electrical pain that radiated from the right scapula up into the right scalp / Severe arthralgias; About 5 minutes after injection, got a temporary electrical pain that radiated from the right scapula up into the right scalp; Also developed injection site pain; Fever; Chills; This is a spontaneous report received from a contactable consumer or other non-healthcare professional (Patient). A 33-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EW0175), via an unspecified route of administration, administered in Left arm on 01Jun2021 at 15:15 (Age at vaccination: 33 years) as dose 2, single for covid-19 immunisation. Medical history included psoriasis from an unknown date and unknown if ongoing and known allergies were reported as none. The patient concomitant medications were not reported. Patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EW0175), via an unspecified route of administration, administered in Left arm on 11May2021 at 15:15 as dose 1, single for covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, was the patient did not diagnosed with COVID-19. Since the vaccination, did not patient been tested for COVID-19. Patient received vaccine facility type in hospital. On 02Jun2021 at 01:30, the patient experienced about 5 minutes after injection, got a temporary electrical pain that radiated from the right scapula up into the right scalp / Severe arthralgias, also developed injection site pain, fever, chills. On 04Jun2021, developed right neck and scalp rash, burning, swelling. On 04Jun2021 at 01:30, the patient experienced also on the right anterior neck area, ear pain. No facial involvement. Patient visited doctor or other healthcare professional office/clinic visit. Treatment was received for the events as Valacyclovir (VALTREX) 1g oral tablet. The outcome of the events was reported as not recovered. Follow-Up (23Aug2021): Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1812872
Sex: F
Age:
State:

Vax Date: 06/06/2021
Onset Date: 06/07/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Migraine; My headache is bad; Fever; The initial case was missing the following minimum criteria: identifiable Event. Upon receipt of follow-up information on 08Jun2021, this case now contains all required information to be considered valid. This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 06Jun2021 as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on unspecified date as dose 1, single for covid-19 immunization. Consumer stated, I just have a question, I got a second dose of Pfizer and on last Saturday it is a 06Jun2021 about two days ago and on Sunday I got a fever on 07Jun2021 but today on 08Jun2021 I have a migraine and today I think my migraine my headache is bad. She just wanted to know if you could take I think migraine medicine after the COVID Shot. The outcome of event was unknown. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1812873
Sex: F
Age:
State: MI

Vax Date: 05/18/2021
Onset Date: 05/18/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Terrible Migraine headache; nausea; light sensitivity; Cold down my arm, then up my arm, & up my neck; felt like a cold blanket was wrapped around my lungs; Felt like I got a halls lozenge stuck in my lungs overnight; What felt like a cold spot in the middle of my brain; Dizziness; Nose was just pouring; Tossing and turning all night couldn't sleep; This is a spontaneous report from a contactable consumer or other non healthcare professional. A 43 year old non pregnant female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 18May2021 12:30 (Batch/Lot Number: Ew0186) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included coeliac disease from an unknown date and unknown if ongoing , drug hypersensitivity from an unknown date and unknown if ongoing known allergies to Penecillin, codeine, morphine, neosporin, gluten. Concomitant medication(s) included naproxen sodium (ALEVE) taken for an unspecified indication, start and stop date were not reported. The patient previously took codeine and experienced drug hypersensitivity, morphine and experienced drug hypersensitivity, neosporine and experienced drug hypersensitivity, gluten and experienced drug hypersensitivity. The patient experienced cold down her arm, then up her arm, & up her neck with feeling cold on 18May2021 13:00 with outcome of unknown, felt like a cold blanket was wrapped around her lungs on 18May2021 13:00 with outcome of unknown, nose was just pouring causing rhinorrhoea on 18May2021 with outcome of recovered , terrible migraine headache on 18May2021 13:00 with outcome of unknown , nausea on 18May2021 13:00 with outcome of unknown,,light sensitivity causing photophobia on 18May2021 13:00 with outcome of unknown , tossing and turning all night couldn't sleep causing insomnia on 18May2021 with outcome of unknown , felt like she got a halls lozenge stuck in her lungs overnight causing chest discomfort on 18May2021 13:00 with outcome of unknown, what felt like a cold spot in the middle of her brain causing cold-stimulus headache on 18May2021 with outcome of unknown and dizziness on 18May2021 with outcome of unknown. Follow-up (14Jul2021): Follow-up attempts are completed. No further information is expected Follow-Up (28Jul2021): Follow-up attempts are completed. No further information is expected.

Other Meds: ALEVE

Current Illness:

ID: 1812874
Sex: M
Age:
State: NY

Vax Date: 06/06/2021
Onset Date: 06/07/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: This is a spontaneous report from a contactable consumer (patient's parent). A 12-year-old male patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, solution for injection, batch/lot# EW0181), at the vaccination age of 12, via an unspecified route of administration, in left arm, on Jun 6, 2021, at 12:00, single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. The patient previously received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, solution for injection, batch/lot# EW0187), at the vaccination age of 12, via an unspecified route of administration, in left arm, on May 16, 2021, at 12:00, single dose, for COVID-19 immunisation. The patient did not take any other vaccine in four weeks. The patient did not have COVID-19 prior to the vaccination. The patient has not tested for COVID-19 post vaccination. On Jun 7, 2021, at 07:00, patient experienced fever for 24 hours (varying between 99?F and 101.6?F), nausea and general malaise. The patient did not take any therapeutic treatment for the adverse events. The outcome of the events resolved on an unspecified date in 2021. Follow-up (Jul 15, 2021): Follow-up attempts completed. No further information expected. Follow-up (Aug 2, 2021): Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1812875
Sex: M
Age:
State: NY

Vax Date: 06/06/2021
Onset Date: 06/07/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210607; Test Name: Fever; Result Unstructured Data: Test Result:99 and 101 degrees Fahrenheit

Allergies:

Symptom List: Vomiting

Symptoms: Fever lasting about 24 hours between 99 and 101 degrees F; Nausea; General malaise; This is a spontaneous report from a contactable consumer or other non healthcare professional (parent). A 12-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, Batch/Lot Number: EW0181, expiry date : not reported), via an unspecified route of administration in the left arm on 06Jun2021 12:15 (at the age of 12-years old) as DOSE 2, SINGLE for covid-19 immunisation at a pharmacy or drug store. The patient had no medical history and there was no known allergies. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Patient did not receive any other medication within 2 weeks of vaccination. Post vaccination, the patient had not been tested for COVID-19. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, Batch/Lot Number: EW0187, expiry date : not reported), via an unspecified route of administration in the left arm on 16May2021 12:15 (at the age of 12-years old) as DOSE 1, SINGLE for covid-19 immunisation. On 07Jun2021 07:00, the patient experienced fever lasting about 24 hours between 99 and 101 degrees Fahrenheit, nausea, general malaise. The patient underwent lab tests and procedures which included Fever: 99 and 101 degrees Fahrenheit on 07Jun2021. No treatment was received for all the reported events. The outcome of the events was recovered in Jun2021. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1812876
Sex: F
Age:
State: FL

Vax Date: 05/18/2021
Onset Date: 05/18/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: nose bleed within a couple hours after both vaccines; This is a spontaneous report from a contactable consumer (patient). A 12-year-old Non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Ew0172) via an unspecified route of administration, administered in Arm Left on 18May2021 18:00 as DOSE 1, SINGLE and second dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Ew0177) via an unspecified route of administration, administered in Arm Left on 08Jun2021 09:15 as DOSE 2, SINGLE (age at vaccination 12 year old) for covid-19 immunisation. Medical history included asthma, anxiety, depression, von Willebrand's disease from an unknown date and unknown if ongoing. Concomitant medication included hydroxyzine hydrochloride (ADARIL); cetirizine hydrochloride (ZYRTEC ALLERGY); escitalopram oxalate (LEXAPRO); montelukast sodium (SINGULA); melatonin (MELATONIN) taken within two weeks. No other vaccine was taken within four weeks. Patient has stated that she had not been diagnosed with COVID -19 prior to vaccination and not been tested since the vaccination. Patient was not pregnant at the time of vaccination. No known allergies. On 18May2021 at 20:00 patient experienced nosebleed within a couple of hours after both vaccines. She has mild von wilibrands but has not had a nosebleed in a while and it may be coincidence but she got a nose bleed within a couple hours after both vaccines. No treatment received for adverse event. Outcome of the event was recovered on an unknown date in 2021. Follow-up attempts are completed. No further information is expected.

Other Meds: ADARIL; ZYRTEC ALLERGY; LEXAPRO; SINGULA; MELATONIN

Current Illness:

ID: 1812877
Sex: F
Age:
State: WI

Vax Date: 06/04/2021
Onset Date: 06/05/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Hives appeared from my hips to my face 24 hours after the first dose.; This is a spontaneous report from a non-contactable consumer. This 25-year-old non-pregnant female consumer reported for herself that she received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EW0172) via an unspecified route of administration on 04Jun2021 at 02:45 PM on right arm (at 25-year-old) as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The past drug event included Nitrofurantoin allergy. No other vaccine was received in four weeks. The patient did not have Covid prior to vaccination and was not tested for covid tested post vaccination. On 05Jun2021 at 05:00 PM the patient experienced hives that appeared from my hips to my face 24 hours after the first dose. No additional symptoms were reported. No treatment was received. The patient was recovering. No follow-up attempts were possible. No further information was expected.

Other Meds:

Current Illness:

ID: 1812878
Sex: U
Age:
State: TX

Vax Date: 06/03/2021
Onset Date: 06/07/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Head pressure; short of breath; Hot and cold; dizzy; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 34-years-old patient of an unspecified gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: EW0191), via an unspecified route of administration, administered in arm left on 03Jun2021 08:30 as dose 1, single (at the age of 34-years-old) for covid-19 immunization. Medical history included reported as none. There were no known allergies. The patient concomitant medications were not reported. The patient did receive any other vaccine in four weeks. The patient did not have covid prior to the vaccination and patient did not test for covid post vaccination. On 07Jun2021 20:45, the patient experienced head pressure, short of breath, hot and cold, dizzy and nausea. The patient did not receive any treatment for the events. The outcome of the events was recovering. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1812879
Sex: F
Age:
State: NY

Vax Date: 06/07/2021
Onset Date: 06/08/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210608; Test Name: body temprature; Result Unstructured Data: Test Result:100 Fahrenheit; Test Date: 202008; Test Name: PCR covid test; Test Result: Negative ; Comments: Nasal Swab

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Tiredness; 100F fever; This is a spontaneous report from a contactable consumer or other non-health care professional. A 12-years-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0177) via intramuscularly, in left arm on 07Jun2021, at 17:15 (at the age of 12-years-old) as dose 2, single for covid-19 immunization. The patient medical history included seasonal allergies. There were no concomitant medications. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EW0179) via intramuscularly, in left arm on 15May2021 at 01:30 PM (at the age of 12-years-old) as dose 1, single for covid-19 immunization. Patient had not received any other vaccines within 4 weeks. Patient had not received any other medications in two weeks. Patient had not been diagnosed with COVID-19 prior to vaccination. patient had no Known allergies. On 08Jun2021 at 15:00, patient experienced tiredness and 100F fever. Therapeutic measures were taken as a result of the events and treatment included 200mg Advil, taken once. The patient underwent lab test and procedure which included SARS-CoV-2 test Negative (Nasal Swab) on an unspecified date in Aug2020, body temperature 100 Fahrenheit on 08Jun2021. Outcome of the events were recovering. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1812880
Sex: F
Age:
State: NY

Vax Date: 04/25/2021
Onset Date: 04/27/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: measles - like rash on face cheeks and between eyebrows (worse on right side); Throat and tongue swelling; Throat and tongue swelling; headache; sore arm; dry and flaky skin; dry and flaky skin; swollen red itchy and painful oval and circular red bumps; Swollen neck lymph nodes; This is a spontaneous report from a contactable consumer (patient). A 45-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number: EW0182) via an unspecified route of administration at arm left on 16May2021 11:00 A.M. (at the age of 45-years-old) as DOSE 2, SINGLE and first dose via an unspecified route of administration at arm left on 25Apr2021 at 11:00 A.M. (Batch/Lot Number: EW0172) as DOSE 1, SINGLE for covid-19 immunisation. The relevant medical history included multiple sclerosis. The prior vaccinations within 4 weeks were reported as none. Prior to the vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. Concomitant medications included baclofen, valaciclovir (VALACYCLOVIR), fampridine (AMPYRA), gabapentin and dextromethorphan hydrobromide monohydrate, quinidine sulfate dihydrate (NUEDEXTA); all from an unspecified date for an unspecified indication. Past drug history included allergies to morphine, codeine and gadolinium. On 27Apr2021 at 12: 00 P.M, the patient experienced throat and tongue swelling, swollen neck lymph nodes, headache, sore arm, measles - like rash on face cheeks and between eyebrows (worse on right side) characterized by swollen red itchy and painful oval and circular red bumps, dry and flaky skin. The patient underwent doctor or other healthcare professional office/clinic visit for claimed events. Therapeutic measures were taken as a result of events included diphenhydramine (BENADRYL), topical corticosteroids, ibuprofen, ice. Outcome of the events was recovered. Follow-up attempts are completed. No further information is expected.

Other Meds: Baclofen; Valacyclovir; Ampyra; Gabapentin; Nuedexta

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am